ATE482212T1 - Pyrrolotriazinverbindungen - Google Patents
PyrrolotriazinverbindungenInfo
- Publication number
- ATE482212T1 ATE482212T1 AT05763768T AT05763768T ATE482212T1 AT E482212 T1 ATE482212 T1 AT E482212T1 AT 05763768 T AT05763768 T AT 05763768T AT 05763768 T AT05763768 T AT 05763768T AT E482212 T1 ATE482212 T1 AT E482212T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- useful
- growth factor
- factor receptors
- pyrrolotriazine compounds
- Prior art date
Links
- 150000003921 pyrrolotriazines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000009465 Growth Factor Receptors Human genes 0.000 abstract 2
- 108010009202 Growth Factor Receptors Proteins 0.000 abstract 2
- 101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 abstract 1
- 102000001301 EGF receptor Human genes 0.000 abstract 1
- 101100118549 Homo sapiens EGFR gene Proteins 0.000 abstract 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 abstract 1
- 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 abstract 1
- 101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 abstract 1
- 101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000019491 signal transduction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58476804P | 2004-07-01 | 2004-07-01 | |
| PCT/US2005/022059 WO2006007468A1 (en) | 2004-07-01 | 2005-06-22 | Pyrrolotriazine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE482212T1 true ATE482212T1 (de) | 2010-10-15 |
Family
ID=35784205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05763768T ATE482212T1 (de) | 2004-07-01 | 2005-06-22 | Pyrrolotriazinverbindungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7102003B2 (de) |
| EP (1) | EP1773791B1 (de) |
| AT (1) | ATE482212T1 (de) |
| DE (1) | DE602005023732D1 (de) |
| ES (1) | ES2350697T3 (de) |
| WO (1) | WO2006007468A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY145634A (en) | 2003-12-29 | 2012-03-15 | Bristol Myers Squibb Co | Pyrrolotriazine compounds as kinase inhibitors |
| TW200600513A (en) * | 2004-06-30 | 2006-01-01 | Bristol Myers Squibb Co | A method for preparing pyrrolotriazine compounds |
| US7504521B2 (en) * | 2004-08-05 | 2009-03-17 | Bristol-Myers Squibb Co. | Methods for the preparation of pyrrolotriazine compounds |
| TW200618803A (en) | 2004-08-12 | 2006-06-16 | Bristol Myers Squibb Co | Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors |
| US7894174B2 (en) * | 2004-08-23 | 2011-02-22 | Monolithic Power Systems, Inc. | Method and apparatus for fault detection scheme for cold cathode fluorescent lamp (CCFL) integrated circuits |
| US7151176B2 (en) * | 2004-10-21 | 2006-12-19 | Bristol-Myers Squibb Company | Pyrrolotriazine compounds |
| TW200635927A (en) * | 2004-12-22 | 2006-10-16 | Bristol Myers Squibb Co | Synthetic process |
| US7514435B2 (en) * | 2005-11-18 | 2009-04-07 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US8063208B2 (en) | 2006-02-16 | 2011-11-22 | Bristol-Myers Squibb Company | Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol |
| CN101453818B (zh) | 2007-11-29 | 2014-03-19 | 杭州茂力半导体技术有限公司 | 放电灯的电路保护和调节装置 |
| US9732320B2 (en) | 2008-01-18 | 2017-08-15 | The Brigham And Women's Hospital, Inc. | Selective differentiation, identification, and modulation of human TH17 cells |
| WO2009126311A1 (en) * | 2008-04-11 | 2009-10-15 | The University Of Texas, M.D. Anderson Cancer Center | Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy |
| WO2010071885A1 (en) | 2008-12-19 | 2010-06-24 | Cephalon, Inc. | Pyrrolotriazines as alk and jak2 inhibitors |
| CA3263309A1 (en) | 2022-08-22 | 2024-02-29 | Iambic Therapeutics, Inc. | HER2 COMPOUNDS AND MODULATION METHODS |
| TW202600564A (zh) * | 2024-02-20 | 2026-01-01 | 美商依安彼克醫療有限公司 | Her2抑制劑之固態形式 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2163399A1 (en) | 1994-11-24 | 1996-05-25 | Katsuhiro Kawano | Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor |
| PL332040A1 (en) | 1996-08-28 | 1999-08-16 | Pfizer | Substitution 6,5-heterobicyclic derivatives |
| IL144977A0 (en) | 1999-05-21 | 2002-06-30 | Bristol Myers Squibb Co | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same |
| US6787545B1 (en) * | 1999-08-23 | 2004-09-07 | Shiongi & Co., Ltd. | Pyrrolotriazine derivatives having spla2-inhibitory activities |
| AU3276002A (en) | 2000-11-17 | 2002-05-27 | Bristol Myers Squibb Co | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| US6670357B2 (en) * | 2000-11-17 | 2003-12-30 | Bristol-Myers Squibb Company | Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| US6867300B2 (en) * | 2000-11-17 | 2005-03-15 | Bristol-Myers Squibb Company | Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| TW200300350A (en) * | 2001-11-14 | 2003-06-01 | Bristol Myers Squibb Co | C-5 modified indazolylpyrrolotriazines |
| PL219736B1 (pl) | 2002-04-23 | 2015-07-31 | Bristol Myers Squibb Co | Pochodna pirolotriazynoaniliny, kompozycja farmaceutyczna i jej zastosowanie |
| ATE418546T1 (de) * | 2002-04-23 | 2009-01-15 | Bristol Myers Squibb Co | Als kinase inhibitoren geeignete arylketonpyrrolotriazin-verbindungen |
| TW200407143A (en) * | 2002-05-21 | 2004-05-16 | Bristol Myers Squibb Co | Pyrrolotriazinone compounds and their use to treat diseases |
| TWI272271B (en) * | 2002-07-19 | 2007-02-01 | Bristol Myers Squibb Co | Process for preparing certain pyrrolotriazine compounds |
| TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
| AU2003265349A1 (en) * | 2002-08-02 | 2004-02-23 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| TW200420565A (en) * | 2002-12-13 | 2004-10-16 | Bristol Myers Squibb Co | C-6 modified indazolylpyrrolotriazines |
-
2005
- 2005-06-21 US US11/157,460 patent/US7102003B2/en not_active Expired - Lifetime
- 2005-06-22 ES ES05763768T patent/ES2350697T3/es not_active Expired - Lifetime
- 2005-06-22 AT AT05763768T patent/ATE482212T1/de not_active IP Right Cessation
- 2005-06-22 WO PCT/US2005/022059 patent/WO2006007468A1/en not_active Ceased
- 2005-06-22 EP EP05763768A patent/EP1773791B1/de not_active Expired - Lifetime
- 2005-06-22 DE DE602005023732T patent/DE602005023732D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1773791A1 (de) | 2007-04-18 |
| EP1773791A4 (de) | 2009-08-26 |
| WO2006007468A1 (en) | 2006-01-19 |
| US7102003B2 (en) | 2006-09-05 |
| US20060014745A1 (en) | 2006-01-19 |
| EP1773791B1 (de) | 2010-09-22 |
| ES2350697T3 (es) | 2011-01-26 |
| DE602005023732D1 (de) | 2010-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY145634A (en) | Pyrrolotriazine compounds as kinase inhibitors | |
| TW200420565A (en) | C-6 modified indazolylpyrrolotriazines | |
| MXPA04004492A (es) | Indazolilpirrolotriazinas c-5 modificadas. | |
| MXPA05000715A (es) | Inhibidores novedosos de cinasas. | |
| WO2006007378A3 (en) | Pyrrolotriazine kinase inhibitors | |
| CY2021019I2 (el) | Παραγωγα ν4-φαινυλ-κιναζολινο-4-αμινης και σχετικες ενωσεις ως αναστολεις υποδοχεα κινασης τυροσινης τυπου i erbb για τη θεραπεια υπερπολλαπλασιαστικων ασθενειων | |
| WO2004001059A3 (en) | Heterocyclic inhibitors of kinases | |
| WO2005065266A3 (en) | Di-substituted pyrrolotriazine compounds | |
| EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
| ATE540696T1 (de) | Erbb2-antagonisten für die tumorschmerztherapie | |
| NO20061320L (no) | Kinazolinderivater som antitumor agenter | |
| NO20026196D0 (no) | Kinazolinditosylatsalt forbindelser | |
| DE602005023732D1 (de) | Pyrrolotriazinverbindungen | |
| SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
| NO20070514L (no) | Pyrrolotriazin kinase inhibitorer | |
| CY1115145T1 (el) | Αλατα του αναστολεα κινασης janus (r)-3-(4-(7h-πyppoλo[2,3-d]πυριμιδιν-4-υλ)-1η-πυραζολ-1-υλ)-3-κυκλοπεντυλο-προπανονιτριλιου | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| ATE478856T1 (de) | Spirobenzodioxole und deren verwendung als cb1- antagonisten | |
| WO2005058245A3 (en) | Synthetic process | |
| EA200601176A1 (ru) | 3-цианохинолиновые производные с антипролиферативной активностью | |
| ATE516291T1 (de) | Thenopyrimidin-verbindungen mit fungizider aktivität | |
| UA90659C2 (ru) | Аналоги хиназолина как ингибиторы рецепторных тирозинкиназ | |
| TW200635927A (en) | Synthetic process | |
| ATE421510T1 (de) | Kompetitive atp-kinasehemmer | |
| WO2006135796A3 (en) | Crystalline forms of a pyrrolotriazine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |